SURESCRIPTS lobbying for SURESCRIPTS

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 8, 2025

Expenses

$10,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Lobbyists on this filing 1

DEANNE PRIMOZIC

Previously held: VP, Policy and Federal Affairs

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Efforts to advance health data interoperability; ensure technological advances in the pharmacy services sector, including electronic prescribing ofcontrolled substances, real-time pharmacy benefit information to patients and other stakeholders. Efforts to promote equitable community access topharmacist services.

Pharmacy

Efforts to advance health data interoperability; ensure technological advances in the pharmacy services sector, including electronic prescribing ofcontrolled substances, real-time pharmacy benefit information to patients and other stakeholders. Efforts to promote equitable community access to pharmacist services.